EQH vs. NVS
EQH (Equitable Holdings, Inc.) and NVS (Novartis AG) are both stocks. EQH operates in Insurance - Diversified (Financial Services), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, EQH returned 12.53%/yr vs 15.13%/yr for NVS. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
EQH vs. NVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EQH achieves a 2.82% return, which is significantly lower than NVS's 14.85% return.
EQH
- 1D
- 1.37%
- 1M
- 5.91%
- 6M
- 4.80%
- YTD
- 2.82%
- 1Y
- -1.08%
- 3Y*
- 21.86%
- 5Y*
- 12.53%
- 10Y*
- —
- ALL TIME*
- 14.33%
NVS
- 1D
- -1.59%
- 1M
- -3.90%
- 6M
- 4.84%
- YTD
- 14.85%
- 1Y
- 37.33%
- 3Y*
- 18.74%
- 5Y*
- 15.13%
- 10Y*
- 10.30%
- ALL TIME*
- 9.03%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $135.95M | $127.92M | $168.33M | |
NVS Novartis AG | $285.34M | $276.07M | $279.43M |
EQH vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
EQH Equitable Holdings, Inc. | 2.82% | 3.17% | 45.04% | 19.63% | -10.17% | 31.00% | 6.52% | 53.13% | -14.75% |
NVS Novartis AG | 14.85% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 11.31% |
Correlation
The correlation between EQH and NVS is 0.21, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.21 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.22 |
Correlation (All Time) Calculated using the full available price history since May 10, 2018 | 0.23 |
Fundamentals
EQH:
$13.10B
NVS:
$292.08B
EQH:
-$4.16
NVS:
$6.63
EQH:
0.84
NVS:
5.32
EQH:
$11.32B
NVS:
$55.63B
EQH:
$6.96B
NVS:
$41.41B
EQH:
-$759.00M
NVS:
$22.26B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EQH vs. NVS — Risk / Return Rank
EQH
NVS
EQH vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Equitable Holdings, Inc. (EQH) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EQH | NVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.77 | ||
| Sortino ratioReturn per unit of downside risk | -2.28 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.30 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.03 | 2.97 | -3.00 |
| Martin ratioReturn relative to average drawdown | -0.06 | 6.95 | -7.01 |
Loading charts...
Drawdowns
EQH vs. NVS - Drawdown Comparison
The maximum EQH drawdown since its inception was -61.33%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for EQH and NVS.
Loading charts...
Drawdown Indicators
| EQH | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.33% | -42.10% | -19.23% |
Max Drawdown (1Y)Largest decline over 1 year | -34.72% | -12.65% | -22.07% |
Max Drawdown (3Y)Largest decline over 3 years | -35.85% | -19.95% | -15.90% |
Max Drawdown (5Y)Largest decline over 5 years | -35.85% | -20.42% | -15.43% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.03% | — |
Current DrawdownCurrent decline from peak | -11.67% | -6.09% | -5.58% |
Average DrawdownAverage peak-to-trough decline | -12.16% | -10.90% | -1.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.68% | 5.39% | +12.29% |
Volatility
EQH vs. NVS - Volatility Comparison
Equitable Holdings, Inc. (EQH) has a higher volatility of 9.40% compared to Novartis AG (NVS) at 7.08%. This indicates that EQH's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EQH | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.40% | 7.08% | +2.32% |
Volatility (6M)Calculated over the trailing 6-month period | 26.79% | 16.14% | +10.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.45% | 21.66% | +10.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.90% | 19.30% | +13.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.62% | 19.74% | +18.88% |
Dividends
EQH vs. NVS - Dividend Comparison
EQH's dividend yield for the trailing twelve months is around 2.94%, less than NVS's 3.11% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EQH Equitable Holdings, Inc. | 2.94% | 2.20% | 1.99% | 2.58% | 2.72% | 2.17% | 2.58% | 2.34% | 1.56% | 0.00% | 0.00% | 0.00% |
NVS Novartis AG | 3.11% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Financials
EQH vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Equitable Holdings, Inc. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EQH vs. NVS - Profitability Comparison
EQH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Equitable Holdings, Inc. reported a gross profit of 3.61B and revenue of 4.23B. Therefore, the gross margin over that period was 85.2%.
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a gross profit of 10.74B and revenue of 14.42B. Therefore, the gross margin over that period was 74.5%.
EQH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Equitable Holdings, Inc. reported an operating income of 0.00 and revenue of 4.23B, resulting in an operating margin of 0.0%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported an operating income of 4.74B and revenue of 14.42B, resulting in an operating margin of 32.8%.
EQH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Equitable Holdings, Inc. reported a net income of 621.00M and revenue of 4.23B, resulting in a net margin of 14.7%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a net income of 3.27B and revenue of 14.42B, resulting in a net margin of 22.7%.
Frequently Asked Questions
EQH and NVS have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EQH has higher volatility (9.40%) compared to NVS (7.08%). In terms of maximum drawdown, EQH dropped -61.33% vs NVS's -42.10%.
NVS currently has the higher Sharpe Ratio (1.74 vs -0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EQH and NVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer